EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Low Natriuretic Peptide Levels and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction

Toru Kondo, Ross Campbell, Pardeep S Jhund, Inder S Anand, Peter E Carson, Carolyn S P Lam, Sanjiv J Shah, Muthiah Vaduganathan, Faiez Zannad, Michael R Zile, Scott D Solomon, John J V McMurray

JACC: Heart Failure · 2024-08 · 12 (8) · 1442-1455

DOI: 10.1016/j.jchf.2024.04.027 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JACC: Heart Failure, 2024-08. Verfasst von Toru Kondo und 11 weiteren Autor:innen. Beteiligte Einrichtung: British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom; Department of Cardiology, Nagoya University …. Hauptthemen laut MEDLINE: Heart Failure, Stroke Volume, Peptide Fragments, Natriuretic Peptide, Brain. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Although some patients with heart failure (HF) with mildly reduced/preserved ejection fraction have low natriuretic peptide levels, there are no large-scale systematic studies of how common these individuals are or what happens to them. OBJECTIVES: The purpose of this study was to examine the proportion of patients in the I-PRESERVE (Irbesartan in Heart Failure with Preserved Ejection Fraction) trial with an N-terminal pro-B-type natriuretic peptide (NT-proBNP) level

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureStroke VolumePeptide FragmentsNatriuretic Peptide, BrainHumansMaleFemaleAgedMiddle AgedTetrazolesIrbesartanHospitalizationBiphenyl CompoundsPrognosisBiomarkersAngiotensin II Type 1 Receptor Blockers

Stichwörter der Autor:innen

body mass indexheart failureheart failure with preserved ejection fractionnatriuretic peptide

Substanzen

Peptide FragmentsNatriuretic Peptide, Brainpro-brain natriuretic peptide (1-76)TetrazolesIrbesartanBiphenyl CompoundsBiomarkersAngiotensin II Type 1 Receptor Blockers

Autor:innen und Institutionen

  • British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
  • VA Medical Center and University of Minnesota, Minneapolis, Minnesota, USA.
  • Rehoboth Beach, Delaware, USA.
  • National Heart Centre Singapore and Duke-National University of Singapore, Singapore.
  • Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Zitieren

APA

Kondo, T., Campbell, R., Jhund, P. S., Anand, I. S., Carson, P. E., Lam, C. S. P., Shah, S. J., Vaduganathan, M., Zannad, F., Zile, M. R., Solomon, S. D., & McMurray, J. J. V. (2024). Low Natriuretic Peptide Levels and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction. JACC: Heart Failure, 12(8), 1442-1455. https://doi.org/10.1016/j.jchf.2024.04.027

Vancouver

Kondo T, Campbell R, Jhund PS, Anand IS, Carson PE, Lam CSP, et al. Low Natriuretic Peptide Levels and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction. JACC: Heart Failure. 2024;12(8):1442-1455. doi:10.1016/j.jchf.2024.04.027

BibTeX
@article{Kondo2024,
  author = {Kondo, Toru and Campbell, Ross and Jhund, Pardeep S and Anand, Inder S and Carson, Peter E and Lam, Carolyn S P and Shah, Sanjiv J and Vaduganathan, Muthiah and Zannad, Faiez and Zile, Michael R and Solomon, Scott D and McMurray, John J V},
  title = {Low Natriuretic Peptide Levels and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction},
  journal = {JACC: Heart Failure},
  year = {2024},
  volume = {12},
  number = {8},
  pages = {1442--1455},
  doi = {10.1016/j.jchf.2024.04.027}
}
Kostenlos starten →